Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 31, Number 6—June 2025

Dispatch

Mycoplasma arginini Cellulitis, Tenosynovitis, and Arthritis in Kidney Transplant Recipient, Slovenia, 2024

Tjaša Vivoda, Tereza Rojko, Barbara Kokošar Ulčar, Katja Strašek Smrdel, Andraž Celar Šturm, Darja Keše, Tina Triglav, and Željka Večerić HalerComments to Author 
Author affiliation: University Medical Center Ljubljana, Ljubljana, Slovenia (T. Vivoda, T. Rojko, B. Kokošar Ulčar, Ž. Večerić Haler); Faculty of Medicine, University of Ljubljana, Ljubljana (T. Vivoda, T. Rojko, K. Strašek Smrdel, D. Keše, T. Triglav, Ž. Večerić Haler); Institute of Microbiology and Immunology, Ljubljana (K. Strašek Smrdel, A. Celar Šturm, D. Keše, T. Triglav)

Main Article

Figure 1

Surgical site after treatment for Mycoplasma arginini cellulitis, tenosynovitis, and arthritis in kidney transplant recipient, Slovenia, 2024. We observed swelling, redness, and restricted joint mobility in the left wrist before surgery.

Figure 1. Surgical site after treatment for Mycoplasma arginini cellulitis, tenosynovitis, and arthritis in kidney transplant recipient, Slovenia, 2024. We observed swelling, redness, and restricted joint mobility in the left wrist before surgery.

Main Article

Page created: April 14, 2025
Page updated: May 27, 2025
Page reviewed: May 27, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external